Presentation is loading. Please wait.

Presentation is loading. Please wait.

FEEDBACK QUESTIONNAIRE 2007. Frequency of samples Sample volume Appropriateness of analyte concentrations Adequacy of the report Website display Usefulness.

Published byDana McDaniel Modified over 8 years ago

Similar presentations

Presentation on theme: "FEEDBACK QUESTIONNAIRE 2007. Frequency of samples Sample volume Appropriateness of analyte concentrations Adequacy of the report Website display Usefulness."— Presentation transcript:

1 FEEDBACK QUESTIONNAIRE 2007

2 Frequency of samples Sample volume Appropriateness of analyte concentrations Adequacy of the report Website display Usefulness of annual report Value for money Billing arrangements Design

3 Scoring 1 234 1-Excellent 2-Good 3-Poor 4-Very poor

4 Responses 2007 20042001 Total Participant794758 Qualitative organic acids50 (31%) Quantitative organic acids30(39%) Quantitative amino acids65(32%) Special assays - urine40 (31%) Special assays - plasma53(30%) Purine/pyrimidine20(39%) Acyl carnitines23(31%) Proficiency schemes36(35%) Cystine in WBC9(32%)

5 Scores 2007 20042001 Average in all aspects in all schemes 1.69 1.952.02 Qualitative organic acids 1.61 1.961.88 Quantitative organic acids 1.73 1.932.06 Quantitative amino acids 1.71 1.922.04 Special assays - urine 1.76 1.902.08 Special assays - plasma 1.73 1.842.03 Purine/pyrimidine 1.56 1.832.08 Acyl carnitines 1.99 2.27- Proficiency schemes 1.67 1.951.96 Cystine in white blood cells 1.43 --

6 2007 20042001 Qualitative organic acids 1.6 1.9 Quantitative organic acids 1.5 1.81.9 Quantitative amino acids 1.5 1.81.7 Special assays - urine 1.5 1.72.0 Special assays - plasma 1.5 1.71.9 Purine/pyrimidine 1.4 1.8 Acyl carnitines 2.2 2.3- Proficiency schemes 1.6 1.91.8 Cystine in white blood cells 1.2 -- Frequency of samples

7 2007 20042001 Qualitative organic acids 1.9 2.22.0 Quantitative organic acids 1.5 1.9 Quantitative amino acids 1.6 2.11.7 Special assays - urine 2.0 1.82.0 Special assays - plasma 1.7 2.02.1 Purine/pyrimidine 1.3 1.61.9 Acyl carnitines 1.9 2.3- Proficiency schemes 2.2 2.1 Cystine in white blood cells 1.4 -- Sample volume

8 2007 20042001 Qualitative organic acids 1.4 1.81.5 Quantitative organic acids 2.0 2.22.1 Quantitative amino acids 1.7 2.22.3 Special assays - urine 1.9 2.02.2 Special assays - plasma 1.8 1.92.1 Purine/pyrimidine 1.6 1.92.2 Acyl carnitines 1.7 2.1- Proficiency schemes 1.7 2.01.9 Cystine in white blood cells 1.3 -- Appropriateness of analyte concentration

9 2007 20042001 Qualitative organic acids 1.3 1.81.5 Quantitative organic acids 1.7 2.12.0 Quantitative amino acids 1.8 2.02.3 Special assays - urine 1.7 2.02.2 Special assays - plasma 1.7 1.92.1 Purine/pyrimidine 1.4 2.02.2 Acyl carnitines 1.7 2.2- Proficiency schemes 1.3 1.9 Cystine in white blood cells 1.3 -- Adequacy of the report

10 2007 20042001 Qualitative organic acids 2.0 2.62.3 Quantitative organic acids 1.9 Quantitative amino acids 1.9 1.82.0 Special assays - urine 1.8 1.92.0 Special assays - plasma 1.8 1.9 Purine/pyrimidine 1.7 1.92.0 Acyl carnitines 2.7 - Proficiency schemes 2.2 2.0 Cystine in white blood cells 1.6 -- Website display

11 2007 20042001 Qualitative organic acids 1.4 1.71.9 Quantitative organic acids 1.8 1.92.1 Quantitative amino acids 1.8 1.92.2 Special assays - urine 1.6 1.82.0 Special assays - plasma 1.7 1.92.0 Purine/pyrimidine 1.6 1.92.4 Acyl carnitines 2.1 2.0- Proficiency schemes 1.2 1.82.0 Cystine in white blood cells 1.5 -- Usefullness of the annual report

12 2007 20042001 Qualitative organic acids 1.7 1.8 Quantitative organic acids 1.8 1.92.1 Quantitative amino acids 1.7 1.82.2 Special assays - urine 1.8 2.1 Special assays - plasma 1.8 2.0 Purine/pyrimidine 1.8 2.22.1 Acyl carnitines 1.9 2.2- Proficiency schemes 1.6 1.81.9 Cystine in white blood cells 1.5 -- Value for money

13 2007 20042001 Qualitative organic acids 1.7 1.92.1 Quantitative organic acids 1.6 1.92.3 Quantitative amino acids 1.7 1.92.2 Special assays - urine 1.7 1.92.0 Special assays - plasma 1.7 1.92.1 Purine/pyrimidine 1.7 1.92.0 Acyl carnitines 1.7 2.5- Proficiency schemes 1.6 1.92.2 Cystine in white blood cells 1.5 -- Billing arrangement

14 Analytes to be added (number of responses>1) Quantitative organic acids 3OHglutarate (n=6) succinylacetone (n=4) Orotate(n=3) Oxalate (n=2) Vanyllactate(n=2) Mevalonate(n=2)

15 Analytes to be added (number of responses>1) Quantitative amino acids Alloisoleucine(n=7) Argininosuccinate (n=4) Phosphoethanolamine(n=3) Saccharopine(n=3) Homocitrulline(n=2) Tryptophane(n=2)

16 Analytes to be added (number of responses>1) Special assays - urine Galactitol(n=3) Mevalonate(n=4) Special assays – plasma Total carnitine(n=4) Cholestanol(n=3) Free fatty acids(n=3) Acetoacetate(n=3)

17 Analytes to be added (number of responses>1) Purine/pyrimidine SAICAR(n=5) Succinyladenosine(n=4) 2,8 dihydroxyadenine(n=3)

18 Analytes to be removed (all responses) Quantitative organic acids 4OHbutyrate (n=1) Quantitative amino acids 1CH3histidine(n=5) Sulphocysteine(n=5) Sarcosine(n=2) Homocystine(n=2)

19 Analytes to be removed (all responses) Special assays – urine hydroxyproline(n=3) Special assays - plasma Galactose (n=1) Purine/pyrimidine creatinine, deoxyuridine, dihydrouracil (n=1)

20 Remarks, comments, suggestions for improvement (1) Scientific experts Never give answer to user comments Website website user friendliness to be improved it is difficult to move between the schemes the reports printed from the website are difficult to read graphical displays for linearity and for comparison with all labs would be helpful use of website for qualitative organic acids and proficiency testing

21 Remarks, comments, suggestions for improvement (2) Quantitative schemes analyte concentrations are sometimes too high or should be closer to what is reported in controls and patients distribute samples all along the year (begin before April) Quantitative amino acids unusual amino acids should not be always the same all along the year problem of zero / trace values sample volume is too low

22 Remarks, comments, suggestions for improvement (3) Acylcarnitines the graphs should be provided in the reports frequency could be higher sample volume is too low delay in receiving the reports is approximately 6 months Proficiency schemes better distribution among the year (2 surveys too close) more urine is needed The attending to ERNDIM meeting in SSIEM should be less expensive

23 Conclusions Remains good overall Improvement in appreciation of all schemes Concerns around website display for qualitative schemes Concerns around sample volume for qualitative organic acids, special assay urine, acylcarnitines and proficiency schemes Some problems with the acylcarnitine scheme

Download ppt "FEEDBACK QUESTIONNAIRE 2007. Frequency of samples Sample volume Appropriateness of analyte concentrations Adequacy of the report Website display Usefulness."

Similar presentations

Copyright 2005, Prentice Hall, Sarafino

Copyright 2005, Prentice Hall, Sarafino
SOME PRACTICAL ISSUES IN COMPOSITE INDEX CONSTRUCTION Lino Briguglio and Nadia Farrugia Department of Economics, University of Malta Prepared for the INTERNATIONAL.

SOME PRACTICAL ISSUES IN COMPOSITE INDEX CONSTRUCTION Lino Briguglio and Nadia Farrugia Department of Economics, University of Malta Prepared for the INTERNATIONAL.
DR D SHANTIR PRACTICE PATIENT PARTICIPATION SURVEY 2011-2012.

DR D SHANTIR PRACTICE PATIENT PARTICIPATION SURVEY
Corporate Card Helpdesk Customer Satisfaction Survey 2005 Feedback Results.

Corporate Card Helpdesk Customer Satisfaction Survey 2005 Feedback Results.
The Newborn Screening Quality Assurance Program. W. Harry Hannon, Ph.D. Chief, Newborn Screening Branch Centers for Disease Control and Prevention.

The Newborn Screening Quality Assurance Program. W. Harry Hannon, Ph.D. Chief, Newborn Screening Branch Centers for Disease Control and Prevention.
Community Perceptions of Westlake City Schools Citizen’s Advisory Committee April 2013.

Community Perceptions of Westlake City Schools Citizen’s Advisory Committee April 2013.
Maine Quality Forum Advisory Council February 8, 2012 Public Reporting of Patient Experience Survey Data.

Maine Quality Forum Advisory Council February 8, 2012 Public Reporting of Patient Experience Survey Data.
Population Population

Population Population
Introduction Goal of this work is to better understand Guelph’s 2007 LibQUAL+ comments (in aggregate), within the context of the quantitative findings.

Introduction Goal of this work is to better understand Guelph’s 2007 LibQUAL+ comments (in aggregate), within the context of the quantitative findings.
Fall 2006 – Fundamentals of Business Statistics 1 Chapter 13 Introduction to Linear Regression and Correlation Analysis.

Fall 2006 – Fundamentals of Business Statistics 1 Chapter 13 Introduction to Linear Regression and Correlation Analysis.
Linear Regression and Correlation Analysis

Linear Regression and Correlation Analysis
1 Validation and Verification of Simulation Models.

1 Validation and Verification of Simulation Models.
Using Market Research. Seeing the Problem Clearly Marketing Research: procedure designed to identify solutions to a specific marketing problem through.

Using Market Research. Seeing the Problem Clearly Marketing Research: procedure designed to identify solutions to a specific marketing problem through.
Başak Karakaya Industrial Engineering Department

Başak Karakaya Industrial Engineering Department
Descriptive Statistics  Summarizing, Simplifying  Useful for comprehending data, and thus making meaningful interpretations, particularly in medium to.

Descriptive Statistics  Summarizing, Simplifying  Useful for comprehending data, and thus making meaningful interpretations, particularly in medium to.
How to Produce Statistical Graphics General Clinical Research Center August 15, 2005 Rachel Enriquez.

How to Produce Statistical Graphics General Clinical Research Center August 15, 2005 Rachel Enriquez.
Bivariate Data Analysis Bivariate Data analysis 3.

Bivariate Data Analysis Bivariate Data analysis 3.
Welcome to Data Analysis and Interpretation

Welcome to Data Analysis and Interpretation
Crofton & Sharlston Medical Practice Questionnaire Results 2013/14 Presentation of 2013/14 Patient Questionnaire Results Patient Participation Group Wednesday.

Crofton & Sharlston Medical Practice Questionnaire Results 2013/14 Presentation of 2013/14 Patient Questionnaire Results Patient Participation Group Wednesday.
Descriptive Statistics  Summarizing, Simplifying  Useful for comprehending data, and thus making meaningful interpretations, particularly in medium to.

Descriptive Statistics  Summarizing, Simplifying  Useful for comprehending data, and thus making meaningful interpretations, particularly in medium to.

Similar presentations

Ads by Google